Green J D, Kreplak L, Goldsbury C, Li Blatter X, Stolz M, Cooper G S, Seelig A, Kistler J, Aebi U
M.E. Müller Institute for Structural Biology, Biozentrum, University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland.
J Mol Biol. 2004 Sep 17;342(3):877-87. doi: 10.1016/j.jmb.2004.07.052.
To date, over 20 peptides or proteins have been identified that can form amyloid fibrils in the body and are thought to cause disease. The mechanism by which amyloid peptides cause the cytotoxicity observed and disease is not understood. However, one of the major hypotheses is that amyloid peptides cause membrane perturbation. Hence, we have studied the interaction between lipid bilayers and the 37 amino acid residue polypeptide amylin, which is the primary constituent of the pancreatic amyloid associated with type 2 diabetes. Using a dye release assay we confirmed that the amyloidogenic human amylin peptide causes membrane disruption; however, time-lapse atomic force microscopy revealed that this did not occur by the formation of defined pores. On the contrary, the peptide induced the formation of small defects spreading over the lipid surface. We also found that rat amylin, which has 84% identity with human amylin but cannot form amyloid fibrils, could also induce similar lesions to supported lipid bilayers. The effect, however, for rat amylin but not human amylin, was inhibited under high ionic conditions. These data provide an alternative theory to pore formation, and how amyloid peptides may cause membrane disruption and possibly cytotoxicity.
迄今为止,已鉴定出20多种可在体内形成淀粉样纤维并被认为会引发疾病的肽或蛋白质。淀粉样肽导致所观察到的细胞毒性和疾病的机制尚不清楚。然而,一个主要假说是淀粉样肽会引起膜扰动。因此,我们研究了脂质双层与由37个氨基酸残基组成的多肽胰淀素之间的相互作用,胰淀素是与2型糖尿病相关的胰腺淀粉样蛋白的主要成分。通过染料释放试验,我们证实了具有淀粉样变性的人胰淀素肽会导致膜破坏;然而,延时原子力显微镜显示,这并非通过形成特定的孔来实现。相反,该肽诱导了在脂质表面扩散的小缺陷的形成。我们还发现,与人胰淀素具有84%同源性但不能形成淀粉样纤维的大鼠胰淀素,也能在支持的脂质双层上诱导类似的损伤。然而,在高离子条件下,大鼠胰淀素(而非人胰淀素)的这种作用受到抑制。这些数据为孔形成以及淀粉样肽如何导致膜破坏和可能的细胞毒性提供了一种替代理论。